We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The molecular details revealed in the study can be further utilised to design piperazine derivative drugs that are more potent and aggressive to fight Chikungunya virus